Fortress Biotech, Inc.
FBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.4% | 24.9% | -13.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.4% | 69.9% | 63.5% | 61.6% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 70.5% | -51.3% | -159.8% | -144% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 33.2% | 94.4% | -80.6% | -44.7% |
| EPS Diluted | 0.11 | 0.45 | -0.48 | -0.37 |
| % Growth | -75.6% | 193.8% | -29.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |